Rosuvastatin-induced thrombocytopenia has been reported.
Rosuvastatin-induced thrombocytopenia.
AI Summary
Key Findings
Abstract
Rosuvastatin, a statin indicated for patients with primary hypercholesterolemia, mixed dyslipidemia and familial hypercholesterolemia, is well tolerated by most patients. Its most common adverse effects are gastrointestinal derangement, muscle aches and hepatitis. One rare complication of statin treatment is severe thrombocytopenia. The case of a 65-year-old patient who developed severe thrombocytopenia while on rosuvastatin is presented, in addition to a review of the literature.
Affiliation
Second Department of Internal Medicine, Propaedeutic, University of Athens, Medical School, Attikon University General Hospital, Haidari, Athens, Greece.
External References
- PubMed ID:
- 20531065
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.